| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |